Anja Krammer, Turn Bio CEO
Stanford spinout racks up more support for its mRNA approach to cellular rejuvenation
As the once-niche field of cellular rejuvenation finds itself under the spotlight on the anti-aging stage — thanks in no small part to Altos Labs’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
